Share-based Payment Arrangement, Expense of CASTLE BIOSCIENCES INC from 30 Jun 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
CASTLE BIOSCIENCES INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2018 to 30 Sep 2025.
  • CASTLE BIOSCIENCES INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $12,100,000, a 7.1% decline year-over-year.
  • CASTLE BIOSCIENCES INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $45,926,000, a 9.4% decline year-over-year.
  • CASTLE BIOSCIENCES INC annual Share-based Payment Arrangement, Expense for 2024 was $50,320,000, a 1.8% decline from 2023.
  • CASTLE BIOSCIENCES INC annual Share-based Payment Arrangement, Expense for 2023 was $51,219,000, a 41% increase from 2022.
  • CASTLE BIOSCIENCES INC annual Share-based Payment Arrangement, Expense for 2022 was $36,321,000, a 67% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

CASTLE BIOSCIENCES INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $45,926,000 $12,100,000 -$927,000 -7.1% 01 Jul 2025 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $46,853,000 $11,208,000 -$1,971,000 -15% 01 Apr 2025 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $48,824,000 $11,179,000 -$1,496,000 -12% 01 Jan 2025 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q4 2024 $50,320,000 $11,439,000 -$363,000 -3.1% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
Q3 2024 $50,683,000 $13,027,000 -$16,000 -0.12% 01 Jul 2024 30 Sep 2024 10-Q 03 Nov 2025 2025 Q3
Q2 2024 $50,699,000 $13,179,000 +$330,000 +2.6% 01 Apr 2024 30 Jun 2024 10-Q 04 Aug 2025 2025 Q2
Q1 2024 $50,369,000 $12,675,000 -$850,000 -6.3% 01 Jan 2024 31 Mar 2024 10-Q 05 May 2025 2025 Q1
Q4 2023 $51,219,000 $11,802,000 +$1,879,000 +19% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $49,340,000 $13,043,000 +$3,847,000 +42% 01 Jul 2023 30 Sep 2023 10-Q 04 Nov 2024 2024 Q3
Q2 2023 $45,493,000 $12,849,000 +$4,066,000 +46% 01 Apr 2023 30 Jun 2023 10-Q 05 Aug 2024 2024 Q2
Q1 2023 $41,427,000 $13,525,000 +$5,106,000 +61% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q4 2022 $36,321,000 $9,923,000 +$3,072,000 +45% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $33,249,000 $9,196,000 +$3,986,000 +77% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $29,263,000 $8,783,000 +$4,017,000 +84% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023 2023 Q2
Q1 2022 $25,246,000 $8,419,000 +$3,506,000 +71% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q4 2021 $21,740,000 $6,851,000 +$3,890,000 +131% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $17,850,000 $5,210,000 +$3,092,000 +146% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 $14,758,000 $4,766,000 +$3,113,000 +188% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q1 2021 $11,645,000 $4,913,000 +$3,336,000 +212% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $8,309,000 $2,961,000 +$2,248,000 +315% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $6,061,000 $2,118,000 +$1,889,000 +825% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021 2021 Q3
Q2 2020 $4,172,000 $1,653,000 +$1,514,000 +1089% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 $2,658,000 $1,577,000 +$1,409,000 +839% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q4 2019 $1,249,000 $713,000 01 Oct 2019 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 $229,000 +$154,608 +208% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2020 Q3
Q2 2019 $139,000 +$54,367 +64% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020 2020 Q2
Q1 2019 $168,000 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q3 2018 $74,392 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $84,633 01 Apr 2018 30 Jun 2018 10-Q 03 Sep 2019 2019 Q2

CASTLE BIOSCIENCES INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $50,320,000 -$899,000 -1.8% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
2023 $51,219,000 +$14,898,000 +41% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $36,321,000 +$14,581,000 +67% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $21,740,000 +$13,431,000 +162% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2023 2022 FY
2020 $8,309,000 +$7,060,000 +565% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2022 2021 FY
2019 $1,249,000 +$955,000 +325% 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2021 2020 FY
2018 $294,000 01 Jan 2018 31 Dec 2018 10-K 10 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.